Position in JNJ
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,379,952,259
+$448,310,207 QoQ
Shares Held
44,808,254
+0.2% QoQ
Ownership
1.86%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#7
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 46%
Shared 0%
None 54%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MORGAN STANLEY holds $63,698,443,803 across 20 Drug Manufacturers - General names. JNJ ranks #2 (17.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
16,226,398 | $19,462,430,163 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
44,808,254 | $11,379,952,259 | |
| 3 | ABBV |
AbbVie Inc.
|
38,901,001 | $9,789,047,884 | |
| 4 | MRK |
Merck & Co., Inc.
|
48,641,158 | $6,250,388,797 | |
| 5 | AMGN |
Amgen Inc
|
13,653,692 | $4,944,274,940 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,004,354 | $3,032,710,073 | |
| 7 | PFE |
Pfizer Inc
|
96,345,452 | $2,319,998,477 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
29,009,025 | $1,671,500,010 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,379,952,259 | 44,808,254 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $10,931,642,052 | 44,721,167 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,587,080,635 | 46,325,589 | Shares | Defined | 2026-05-27 | |
| 2025-09-30 | $8,943,115,683 | 48,231,667 | Shares | Defined | 2026-05-27 | |
| 2025-06-30 | $7,176,938,426 | 46,984,867 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $7,633,729,454 | 46,030,689 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $6,350,183,203 | 43,909,440 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $7,318,974,616 | 45,162,129 | Shares | Defined | 2025-05-14 | |
| 2024-06-30 | $6,148,844,351 | 42,069,269 | Shares | Defined | 2025-05-14 | |
| 2024-03-31 | $6,730,975,474 | 42,549,943 | Shares | Defined | 2024-10-17 | |
| 2023-12-31 | $6,529,706,729 | 41,659,479 | Shares | Defined | 2024-08-16 | |
| 2023-09-30 | $6,423,924,475 | 41,245,101 | Shares | Defined | 2023-11-15 | |
| 2023-06-30 | $6,897,089,120 | 41,669,219 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,200,545,600 | 40,003,520 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,458,961,626 | 42,224,521 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,159,237,056 | 37,703,459 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,730,471,106 | 37,916,011 | Shares | Defined | 2022-10-27 | |
| 2022-03-31 | $4,610,229,930 | 26,012,695 | Shares | Defined | 2022-10-27 | |
| 2021-12-31 | $4,405,708,548 | 25,753,835 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $4,020,707,388 | 24,896,021 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $4,129,495,401 | 25,066,744 | Shares | Defined | 2021-08-23 | |
| 2021-03-31 | $3,994,682,549 | 24,305,948 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $3,794,593,583 | 24,111,028 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $3,345,745,248 | 22,472,765 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $3,028,999,889 | 21,538,789 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $2,727,691,904 | 20,801,433 | Shares | Defined | 2020-05-26 | |
| No filing history on record for this holder in this stock. | ||||||